[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Pharmaceutical Stability & Storage Services Market Size, Share & Trends Analysis Report By Services (Stability, Storage), By Molecule (Large Molecule, Small Molecule), By Mode, By Region, And Segment Forecasts, 2022 - 2030

May 2022 | 275 pages | ID: P3F18952258DEN
Grand View Research, Inc.

US$ 5,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report can be delivered to the clients within 3 Business Days

Pharmaceutical Stability & Storage Services Market Growth & Trends

The global pharmaceutical stability & storage services market size is expected to reach USD 4.4 billion by 2030, registering a CAGR of 5.6% from 2022 to 2030, according to a new report by Grand View Research, Inc. Stability and storage is a mandatory regulation in various regions. For instance, different regulatory authorities have different data requirements and testing rules for testing stability. Even though FDA and EMA follow the ICH guidelines for stability testing, they still have different microbiological limits for stability tests. This has improved the demand for stability testing outsourcing services and is likely to have a positive impact on the market.

The COVID-19 pandemic had increased the demand for COVID-19 vaccines globally. The growing vaccine drive by the government authorities is likely to drive the demand for stability and storage of commercial COVID-19 vaccines. In recent years pharmaceutical R&D spending has improved significantly. The growing R&D spending is expected to improve the number of drugs in the clinical stage. Stability testing is required for the approval of each phase of a clinical trial. This is further driving the market growth. Moreover, Biosimilar drugs are highly similar copies of biologics and are very cheaper, as compared to biologics.

Biosimilar drugs are widely used in cancer, autoimmune diseases, and other diseases. This is contributing to the demand for biosimilar drugs and thereby is expected to drive the market demand. There has been a rise in several diseases post-COVID-19. For instance, according to a report published by Children’s National Hospital- pediatric research and clinical innovations center, a study was performed on 737 youths who were diagnosed with diabetes, and it found an increased incidence of pediatric Type 1 Diabetes (T1D) by 15.2% and Type 2 Diabetes (T2D) increased by 182% between March 11, 2018, and March 10, 2021. The rise in the disease incidence is expected to improve, drug production, which is likely to drive the market demand.

Pharmaceutical Stability & Storage Services Market Report Highlights
  • The stability segment has accounted for the largest revenue share of 72.8% in 2021 as it is a mandatory requirement of the regulatory authority. Stability testing is required for the approval of drugs in all stages of clinical studies this further contributes to its demand in the market
  • The large molecule segment is expected to rise with the fastest CAGR of 6.6% during the forecast period. This can be attributed to the fact that large molecules are widely used in the treatment of cancer and infectious diseases. The ongoing COVID-19 pandemic has further improved the demand for large molecules like vaccines to curb the spread of COVID-19 globally
  • Based on the mode the outsourcing segment is likely to grow with the fastest CAGR of 6.2% over the forecast owing to the complexities associated with stability testing
  • North America has held the largest share in 2021 due to the presence of a significant number of stability storage service providers in the region

CHAPTER 1 METHODOLOGY AND SCOPE

1.1 Market Segmentation & Scope
  1.1.1 Regional Scope
  1.1.2 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
  1.3.1 Purchased Database
  1.3.2 GVR’S Internal Database
  1.3.3 Secondary Sources
  1.3.4 Primary Research
  1.3.5 Details Of Primary Research
1.4 Information or Data Analysis
  1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
  1.6.1 Commodity Flow Analysis (Model 1)
  1.6.2 Volume Price Analysis (Model 2)
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 List of Abbreviations
1.10 Objectives
  1.10.1 Objective - 1:
  1.10.2 Objective - 2:
  1.10.3 Objective - 3:
  1.10.4 Objective - 4:

CHAPTER 2 EXECUTIVE SUMMARY

2.1 Market Outlook

CHAPTER 3 PHARMACEUTICAL STABILITY AND STORAGE SERVICES MARKET: VARIABLES, TRENDS, & SCOPE

3.1 Segment Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Market Dynamics
  3.3.1 Market Driver Analysis
    3.3.1.1 High R&D spending of pharmaceutical & biotechnology companies
    3.3.1.1 Growing demand for outsourcing stability testing due to high complexity associatied with drug stability
    3.3.1.2 Growing demand for biosimilars
  3.3.2 Market Restraint Analysis
    3.3.2.1 Strict regulations for global Pharmaceutical Stability and Storage Services drugs
    3.3.2.2 Issues associated with stability chambers
3.4 Pharmaceutical Stability and Storage Services Market Analysis Tools
  3.4.1 Porter’s Five Forces Analysis
  3.4.2 Pestel Analysis
    3.4.2.1 Political & legal Landscape
      3.4.2.1.1 Strength
      3.4.2.1.2 Weakness
      3.4.2.1.3 Opportunity
      3.4.2.1.4 Threat
    3.4.2.2 Economical Landscape
      3.4.2.2.1 Strength
      3.4.2.2.2 Weakness
      3.4.2.2.3 Opportunity
      3.4.2.2.4 Threat
    3.4.2.3 Social and Technology Landscape
      3.4.2.3.1 Strength
      3.4.2.3.2 Weakness
      3.4.2.3.3 Opportunity
      3.4.2.3.4 Threat
  3.4.3 Major Deals & Strategic Alliances Analysis
    3.4.3.1 Expansion
    3.4.3.2 Aqusition
    3.4.3.3 Partnerships and Collaborations
3.5 COVID-19 Impact Analysis
3.6 Cost structure of stability and storage

CHAPTER 4 PHARMACEUTICAL STABILITY AND STORAGE SERVICES MARKET: SERVICE SEGMENT ANALYSIS

4.1 Definitions & Scope
4.2 Pharmaceutical Stability and Storage Services Market: Service Share Analysis, 2021 & 2030
4.3 Stability Testing
  4.3.1 Market estimates and forecast, 2018 - 2030 (USD MILLION)
  4.3.2 Drug Substance
    4.3.2.1 Market estimates and forecast, (USD Million)
  4.3.3 Stability Indicating Method Validation
    4.3.3.1 Market estimates and forecast, 2018 - 2030 (USD Million)
  4.3.4 Accelerated Stability Testing
    4.3.4.1 Market estimates and forecast, 2018 - 2030 (USD Million)
  4.3.5 Photostability Testing
    4.3.5.1 Market estimates and forecast, 2018 - 2030 (USD Million)
  4.3.6 Others
    4.3.6.1 Market estimates and forecast, 2018 - 2030 (USD Million)
4.4 Storage
  4.4.1 Market estimates and forecast, 2018 - 2030 (USD MILLION)
  4.4.2 Cold
    4.4.2.1 Market estimates and forecast, 2018 - 2030 (USD MILLION)
  4.4.3 Non-Cold
    4.4.3.1 Market estimates and forecast, 2018 - 2030 (USD MILLION)

CHAPTER 5 PHARMACEUTICAL STABILITY AND STORAGE SERVICES MARKET: MOLECULE TYPE SEGMENT ANALYSIS

5.1 Definition & Scope
5.2 Pharmaceutical Stability and Storage Services Market: Molecule Share Analysis, 2021 & 2030
5.3 Small Molecule
  5.3.1 Market estimates and forecast, 2018 - 2030 (USD MILLION)
  5.3.2 Research Products
    5.3.2.1 Market estimates and forecast, 2018 - 2030 (USD MILLION)
  5.3.3 Commercial Products
    5.3.3.1 Market estimates and forecast, 2018 - 2030 (USD MILLION)
5.4 Large Molecule
  5.4.1 Market estimates and forecast, 2018 - 2030 (USD MILLION)
  5.4.2 Research Products
    5.4.2.1 Market estimates and forecast, 2018 - 2030 (USD MILLION)
  5.4.3 Commercial Products
    5.4.3.1 Market estimates and forecast, 2018 - 2030 (USD MILLION)

CHAPTER 6 PHARMACEUTICAL STABILITY AND STORAGE SERVICES MARKET: MODE SEGMENT ANALYSIS

6.1 Definitions & Scope
6.2 Pharmaceutical Stability and Storage Services Market: Mode Share Analysis, 2021 & 2030
6.3 In-house
  6.3.1 Market estimates and forecast, 2018 - 2030 (USD MILLION)
6.4 Outsourcing
  6.4.1 Market estimates and forecast, 2018 - 2030 (USD MILLION)

CHAPTER 7 PHARMACEUTICAL STABILITY AND STORAGE SERVICES MARKET: REGIONAL ANALYSIS

7.1 Pharmaceutical Stability and Storage Services Market: Regional Share Analysis, 2021 & 2030
7.2 North America
  7.2.1 Market estimates and forecast, 2018 - 2030 (USD Million)
  7.2.2 U.S.
    7.2.2.1 Market estimates and forecast, 2018 - 2030 (USD Million)
  7.2.3 Canada
    7.2.3.1 Market estimates and forecast, 2018 - 2030 (USD Million)
7.3 Europe
  7.3.1 Market estimates and forecast, 2018 - 2030 (USD Million)
  7.3.2 UK
    7.3.2.1 Market estimates and forecast, 2018 - 2030 (USD Million)
  7.3.3 Germany
    7.3.3.1 Market estimates and forecast, 2018 - 2030 (USD Million)
  7.3.4 France
    7.3.4.1 Market estimates and forecast, 2018 - 2030 (USD Million)
  7.3.5 Italy
    7.3.5.1 Market estimates and forecast, 2018 - 2030 (USD Million)
  7.3.6 Spain
    7.3.6.1 Market estimates and forecast, 2018 - 2030 (USD Million)
7.4 Asia Pacific
  7.4.1 Market estimates and forecasts, 2018 - 2030
  7.4.2 Japan
    7.4.2.1 Market estimates and forecasts, 2018 - 2030
  7.4.3 China
    7.4.3.1 Market estimates and forecasts, 2018 - 2030
  7.4.4 India
    7.4.4.1 Market estimates and forecasts, 2018 - 2030
  7.4.5 South korea
    7.4.5.1 Market estimates and forecasts, 2018 - 2030
  7.4.6 Australia
    7.4.6.1 Market estimates and forecasts, 2018 - 2030
7.5 Latin America
  7.5.1 Market estimates and forecasts, 2018 - 2030
  7.5.2 Brazil
    7.5.2.1 Market estimates and forecasts, 2018 - 2030
  7.5.3 Mexico
    7.5.3.1 Market estimates and forecasts,2018 - 2030
  7.5.4 Argentina
    7.5.4.1 Market estimates and forecasts, 2018 - 2030
7.6 MEA
  7.6.1 Market estimates and forecasts, 2018 - 2030
  7.6.2 South Africa
    7.6.2.1 Market estimates and forecasts, 2018 - 2030
  7.6.3 South Arabia
    7.6.3.1 Market estimates and forecasts, 2018 - 2030

CHAPTER 8 COMPANY PROFILES

8.1 Company Profiles
  8.1.1 Catalent, Inc.
    8.1.1.1 Company Overview
    8.1.1.2 Financial performance
    8.1.1.3 Service benchmarking
    8.1.1.4 Strategic initiatives
  8.1.2 Almac Group
    8.1.2.1 Company overview
    8.1.2.2 Financial performance
    8.1.2.3 Service benchmarking
  8.1.3 Charles River Laboratories International, Inc.
    8.1.3.1 Company overview
    8.1.3.2 Financial performance
    8.1.3.3 Service benchmarking
    8.1.3.4 Strategic initiatives
  8.1.4 Eurofins Scientific
    8.1.4.1 Company overview
    8.1.4.2 Financial performance
    8.1.4.3 Service benchmarking
    8.1.4.4 Strategic Initiatives
  8.1.5 Intertek Group Plc
    8.1.5.1 Company overview
    8.1.5.2 Financial performance
    8.1.5.3 Service benchmarking
    8.1.5.4 Strategic Initiatives
  8.1.6 Lucideon Limited
    8.1.6.1 Company overview
    8.1.6.2 Financial performance
    8.1.6.3 Service benchmarking
    8.1.6.4 Strategic Initiatives
  8.1.7 Alcami Corporation
    8.1.7.1 Company overview
    8.1.7.2 Financial performance
    8.1.7.3 Service benchmarking
    8.1.7.4 Strategic Initiatives
  8.1.8 Element Materials Technology
    8.1.8.1 Company overview
    8.1.8.2 Financial performance
    8.1.8.3 Service benchmarking
    8.1.8.4 Strategic Initiatives
  8.1.9 BioLife Solutions
    8.1.9.1 Company overview
    8.1.9.2 Financial performance
    8.1.9.3 Service benchmarking
    8.1.9.4 Strategic Initiatives
  8.1.10 Q1 Scientific
    8.1.10.1 Company overview
    8.1.10.2 Financial performance
    8.1.10.3 Service benchmarking
    8.1.10.4 Strategic Initiatives
  8.1.11 Masy BioServices
    8.1.11.1 Company overview
    8.1.11.2 Financial performance
    8.1.11.3 Service benchmarking
    8.1.11.4 Strategic Initiatives
  8.1.12 Reading Scientific Services Ltd.
    8.1.12.1 Company overview
    8.1.12.2 Financial performance
    8.1.12.3 Service benchmarking
    8.1.12.4 Strategic Initiatives
  8.1.13 Roylance Stability Storage Limited
    8.1.13.1 Company overview
    8.1.13.2 Financial performance
    8.1.13.3 Service benchmarking
    8.1.13.4 Strategic Initiatives
  8.1.14 Als Ltd.
    8.1.14.1 Company overview
    8.1.14.2 Financial performance
    8.1.14.3 Service benchmarking
    8.1.14.4 Strategic Initiatives
  8.1.15 Q Laboratories
    8.1.15.1 Company overview
    8.1.15.2 Financial performance
    8.1.15.3 Service benchmarking
  8.1.16 Auriga Research Private Limited
    8.1.16.1 Company overview
    8.1.16.2 Financial performance
    8.1.16.3 Service benchmarking
  8.1.17 PD Partners
    8.1.17.1 Company overview
    8.1.17.2 Financial performance
    8.1.17.3 Service benchmarking
  8.1.18 Precision Stability Storage
    8.1.18.1 Company overview
    8.1.18.2 Financial performance
    8.1.18.3 Service benchmarking
    8.1.18.4 Strategic Initiatives

LIST OF TABLES

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Pharmaceutical Stability & Storage Market, by Region, 2018 - 2030 (USD Million)
Table 4 Global Pharmaceutical Stability & Storage Market, by Service 2018 - 2030 (USD Million)
Table 5 Global Pharmaceutical Stability & Storage Market, by Molecule, 2018 - 2030 (USD Million)
Table 6 Global Pharmaceutical Stability & Storage Market, by Mode, 2018 - 2030 (USD Million)
Table 7 North America Pharmaceutical Stability & Storage Market, by Country, 2018 - 2030 (USD Million)
Table 8 North America Pharmaceutical Stability & Storage Market, by Service, 2018 - 2030 (USD Million)
Table 9 North America Pharmaceutical Stability & Storage Market, by Molecule, 2018 - 2030 (USD Million)
Table 10 North America Pharmaceutical Stability & Storage Market, by Mode , 2018 - 2030 (USD Million)
Table 11 U.S. Pharmaceutical Stability & Storage Market, by Service, 2018 - 2030 (USD Million)
Table 12 U.S. Pharmaceutical Stability & Storage Market, by Molecule, 2018 - 2030 (USD Million)
Table 13 U.S. Pharmaceutical Stability & Storage Market, by Mode , 2018 - 2030 (USD Million)
Table 14 Canada Pharmaceutical Stability & Storage Market, by Service, 2018 - 2030 (USD Million)
Table 15 Canada Pharmaceutical Stability & Storage Market, by Molecule, 2018 - 2030 (USD Million)
Table 16 Canada Pharmaceutical Stability & Storage Market, by Mode , 2018 - 2030 (USD Million)
Table 17 Europe Pharmaceutical Stability & Storage Market, by Country, 2018 - 2030 (USD Million)
Table 18 Europe Pharmaceutical Stability & Storage Market, by Service, 2018 - 2030 (USD Million)
Table 19 Europe Pharmaceutical Stability & Storage Market, by Molecule, 2018 - 2030 (USD Million)
Table 20 Europe Pharmaceutical Stability & Storage Market, by Mode , 2018 - 2030 (USD Million)
Table 21 UK Pharmaceutical Stability & Storage Market, by Service, 2018 - 2030 (USD Million)
Table 22 UK Pharmaceutical Stability & Storage Market, by Molecule, 2018 - 2030 (USD Million)
Table 23 UK Pharmaceutical Stability & Storage Market, by Mode , 2018 - 2030 (USD Million)
Table 24 Germany Pharmaceutical Stability & Storage Market, by Service, 2018 - 2030 (USD Million)
Table 25 Germany Pharmaceutical Stability & Storage Market, by Molecule, 2018 - 2030 (USD Million)
Table 26 Germany Pharmaceutical Stability & Storage Market, by Mode , 2018 - 2030 (USD Million)
Table 27 France Pharmaceutical Stability & Storage Market, by Service, 2018 - 2030 (USD Million)
Table 28 France Pharmaceutical Stability & Storage Market, by Molecule, 2018 - 2030 (USD Million)
Table 29 France Pharmaceutical Stability & Storage Market, by Mode , 2018 - 2030 (USD Million)
Table 30 Italy Pharmaceutical Stability & Storage Market, by Service, 2018 - 2030 (USD Million)
Table 31 Italy Pharmaceutical Stability & Storage Market, by Molecule, 2018 - 2030 (USD Million)
Table 32 Italy Pharmaceutical Stability & Storage Market, by Mode , 2018 - 2030 (USD Million)
Table 33 Spain Pharmaceutical Stability & Storage Market, by Service, 2018 - 2030 (USD Million)
Table 34 Spain Pharmaceutical Stability & Storage Market, by Molecule, 2018 - 2030 (USD Million)
Table 35 Spain Pharmaceutical Stability & Storage Market, by Mode , 2018 - 2030 (USD Million)
Table 36 Asia Pacific Pharmaceutical Stability & Storage Market, by Country, 2018 - 2030 (USD Million)
Table 37 Asia Pacific Pharmaceutical Stability & Storage Market, by Service, 2018 - 2030 (USD Million)
Table 38 Asia Pacific Pharmaceutical Stability & Storage Market, by Molecule, 2018 - 2030 (USD Million)
Table 39 Asia Pacific Pharmaceutical Stability & Storage Market, by Mode , 2018 - 2030 (USD Million)
Table 40 Japan Pharmaceutical Stability & Storage Market, by Service, 2018 - 2030 (USD Million)
Table 41 Japan Pharmaceutical Stability & Storage Market, by Molecule, 2018 - 2030 (USD Million)
Table 42 Japan Pharmaceutical Stability & Storage Market, by Mode , 2018 - 2030 (USD Million)
Table 43 China Pharmaceutical Stability & Storage Market, by Service, 2018 - 2030 (USD Million)
Table 44 China Pharmaceutical Stability & Storage Market, by Molecule, 2018 - 2030 (USD Million)
Table 45 China Pharmaceutical Stability & Storage Market, by Mode , 2018 - 2030 (USD Million)
Table 46 India Pharmaceutical Stability & Storage Market, by Service, 2018 - 2030 (USD Million)
Table 47 India Pharmaceutical Stability & Storage Market, by Molecule, 2018 - 2030 (USD Million)
Table 48 India Pharmaceutical Stability & Storage Market, by Mode , 2018 - 2030 (USD Million)
Table 49 Australia Pharmaceutical Stability & Storage Market, by Service, 2018 - 2030 (USD Million)
Table 50 Australia Pharmaceutical Stability & Storage Market, by Molecule, 2018 - 2030 (USD Million)
Table 51 Australia Pharmaceutical Stability & Storage Market, by Mode , 2018 - 2030 (USD Million)
Table 52 South Korea Pharmaceutical Stability & Storage Market, by Service, 2018 - 2030 (USD Million)
Table 53 South Korea Pharmaceutical Stability & Storage Market, by Molecule, 2018 - 2030 (USD Million)
Table 54 South Korea Pharmaceutical Stability & Storage Market, by Mode , 2018 - 2030 (USD Million)
Table 55 Latin America Pharmaceutical Stability & Storage Market, by Country, 2018 - 2030 (USD Million)
Table 56 Latin America Pharmaceutical Stability & Storage Market, by Service, 2018 - 2030 (USD Million)
Table 57 Latin America Pharmaceutical Stability & Storage Market, by Molecule, 2018 - 2030 (USD Million)
Table 58 Latin America Pharmaceutical Stability & Storage Market, by Mode , 2018 - 2030 (USD Million)
Table 59 Brazil Pharmaceutical Stability & Storage Market, by Service, 2018 - 2030 (USD Million)
Table 60 Brazil Pharmaceutical Stability & Storage Market, by Molecule, 2018 - 2030 (USD Million)
Table 61 Brazil Pharmaceutical Stability & Storage Market, by Mode , 2018 - 2030 (USD Million)
Table 62 Mexico Pharmaceutical Stability & Storage Market, by Service, 2018 - 2030 (USD Million)
Table 63 Mexico Pharmaceutical Stability & Storage Market, by Molecule, 2018 - 2030 (USD Million)
Table 64 Mexico Pharmaceutical Stability & Storage Market, by Mode , 2018 - 2030 (USD Million)
Table 65 Argentina Pharmaceutical Stability & Storage Market, by Service, 2018 - 2030 (USD Million)
Table 66 Argentina Pharmaceutical Stability & Storage Market, by Molecule, 2018 - 2030 (USD Million)
Table 67 Argentina Pharmaceutical Stability & Storage Market, by Mode , 2018 - 2030 (USD Million)
Table 68 MEA Pharmaceutical Stability & Storage Market, by Country, 2018 - 2030 (USD Million)
Table 69 MEA Pharmaceutical Stability & Storage Market, by Service, 2018 - 2030 (USD Million)
Table 70 MEA Pharmaceutical Stability & Storage Market, by Molecule, 2018 - 2030 (USD Million)
Table 71 MEA Pharmaceutical Stability & Storage Market, by Mode , 2018 - 2030 (USD Million)
Table 72 South Africa Pharmaceutical Stability & Storage Market, by Service, 2018 - 2030 (USD Million)
Table 73 South Africa Pharmaceutical Stability & Storage Market, by Molecule, 2018 - 2030 (USD Million)
Table 74 South Africa Pharmaceutical Stability & Storage Market, by Mode , 2018 - 2030 (USD Million)
Table 75 Saudi Arabia Pharmaceutical Stability & Storage Market, by Service, 2018 - 2030 (USD Million)
Table 76 Saudi Arabia Pharmaceutical Stability & Storage Market, by Molecule, 2018 - 2030 (USD Million)
Table 77 Saudi Arabia Pharmaceutical Stability & Storage Market, by Mode , 2018 - 2030 (USD Million)

LIST OF FIGURES

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Market formulation & validation
Fig. 6 Commodity flow analysis
Fig. 7 Volume price analysis
Fig. 8 Pharmaceutical Stability and Storage Services Market snapshot (2021) (USD Million)
Fig. 9 Pharmaceutical Stability and Storage Services Market segmentation
Fig. 10 Penetration & growth prospect mapping
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Pharmaceutical R&D spending, 2015-2021 (USD billion)
Fig. 13 Biosimilar approval in the U.S. and EU per year (2016-2021)
Fig. 14 Market restraint relevance analysis (Current & future impact)
Fig. 15 Porter’s five forces analysis
Fig. 16 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 17 Pharmaceutical Stability and Storage Services Market service outlook: Segment dashboard
Fig. 18 Pharmaceutical Stability and Storage Services Market: Service movement analysis
Fig. 19 Stability testing market, 2018 - 2030 (USD Million)
Fig. 20 Drug substance market, 2018 - 2030 (USD Million)
Fig. 21 Stability indicating method validation market, 2018 - 2030 (USD Million)
Fig. 22 Accelerated stability testing market, 2018 - 2030 (USD Million)
Fig. 23 Photostability testing market, 2018 - 2030 (USD Million)
Fig. 24 Others market, 2018 - 2030 (USD Million)
Fig. 25 Storage market, 2018 - 2030 (USD Million)
Fig. 26 Cold market, 2018 - 2030 (USD Million)
Fig. 27 Non-cold market, 2018 - 2030 (USD Million)
Fig. 28 Pharmaceutical Stability and Storage Services Market Molecule Outlook: Segment dashboard
Fig. 29 Pharmaceutical Stability and Storage Services Market: Molecule Movement Analysis
Fig. 30 Small molecule market, 2018 - 2030 (USD Million)
Fig. 31 Research products market, 2018 - 2030 (USD Million)
Fig. 32 Commercial products market, 2018 - 2030 (USD Million)
Fig. 33 Large molecule market, 2018 - 2030 (USD Million)
Fig. 34 Research products market, 2018 - 2030 (USD Million)
Fig. 35 Commercial product market, 2018 - 2030 (USD Million)
Fig. 36 Pharmaceutical Stability and Storage Services Market Mode outlook: Segment dashboard
Fig. 37 Pharmaceutical Stability and Storage Services Market: Mode movement analysis
Fig. 38 In-house market, 2018 - 2030 (USD Million)
Fig. 39 Outsourcing market, 2018 - 2030 (USD Million)
Fig. 40 Regional market: Key takeaways
Fig. 41 Regional outlook, 2021 & 2030
Fig. 42 North America Pharmaceutical Stability and Storage Services Market, 2018 - 2030 (USD Million)
Fig. 43 U.S. Pharmaceutical Stability and Storage Services Market, 2018 - 2030 (USD Million)
Fig. 44 Canada Pharmaceutical Stability and Storage Services Market, 2018 - 2030 (USD Million)
Fig. 45 Europe Pharmaceutical Stability and Storage Services Market, 2018 - 2030 (USD Million)
Fig. 46 UK Pharmaceutical Stability and Storage Services Market, 2018 - 2030 (USD Million)
Fig. 47 Germany Pharmaceutical Stability and Storage Services Market, 2018 - 2030 (USD Million)
Fig. 48 France Pharmaceutical Stability and Storage Services Market, 2018 - 2030 (USD Million)
Fig. 49 Italy Pharmaceutical Stability and Storage Services Market, 2018 - 2030 (USD Million)
Fig. 50 Spain Pharmaceutical Stability and Storage Services Market, 2018 - 2030 (USD Million)
Fig. 51 Asia Pacific Pharmaceutical Stability and Storage Services Market, 2018 - 2030 (USD Million)
Fig. 52 Japan Pharmaceutical Stability and Storage Services Market, 2018 - 2030 (USD Million)
Fig. 53 China Pharmaceutical Stability and Storage Services Market, 2018 - 2030 (USD Million)
Fig. 53 India Pharmaceutical Stability and Storage Services Market, 2018 - 2030 (USD Million)
Fig. 54 Australia Pharmaceutical Stability and Storage Services Market, 2018 - 2030 (USD Million)
Fig. 55 South Korea Pharmaceutical Stability and Storage Services Market, 2018 - 2030 (USD Million)
Fig. 56 Latin America Pharmaceutical Stability and Storage Services Market, 2018 - 2030 (USD Million)
Fig. 57 BrazilPharmaceutical Stability and Storage Services Market, 2018 - 2030 (USD Million)
Fig. 58 Mexico Pharmaceutical Stability and Storage Services Market, 2018 - 2030 (USD Million)
Fig. 59 Argentina Pharmaceutical Stability and Storage Services Market, 2018 - 2030 (USD Million)
Fig. 60 MEA Pharmaceutical Stability and Storage Services Market, 2018 - 2030 (USD Million)
Fig. 61 South Africa Pharmaceutical Stability and Storage Services Market, 2018 - 2030 (USD Million)
Fig. 62 Saudi Arabia Pharmaceutical Stability and Storage Services Market, 2018 - 2030 (USD Million)


More Publications